T. Shimizu et al.
Bull. Chem. Soc. Jpn., 77, No. 2 (2004)
377
13C NMR (125 MHz, CDCl3) ꢁ 21.4, 21.6, 126.5, 127.1 (dupli-
cate), 129.1, 130.4, 131.1, 134.3, 137.1, 140.7, 141.5, 142.1,
145.7; 77Se NMR (95 MHz, CDCl3) ꢁ 884; IR (KBr) ꢂmax 2924,
1598, 1447, 1300, 1144, 1088, 1059, 928 (N=Se=O), 858, 809,
745, 711, 668, 573, 550, 488, 463, 405 cmꢃ1; UV (MeCN) ꢃmax
232 (" 2:52 ꢁ 104), 262 (sh, " 2:70 ꢁ 103) nm; MS m=z 248
{Mþ(80Se)-C7H7NO3S, 41%}, 246 {Mþ(78Se)-C7H7NO3S,
21%}, 168 (100%), 107 (24%), 91 (93%), 65 (45%). Anal. Calcd
for C20H19NO3SSe: C, 55.56; H, 4.43; N, 3.24%. Found: C,
55.38; H, 4.49; N, 3.19%.
dissolved in eluent (0.5 mL), was charged to an optically active
column (Daicel Chiralcel OD: 250 ꢁ 10 mm) and eluted with hex-
ane containing 30 (for 1) and 50 (for 2–4) vol % 2-propanol at a
flow rate of 1.0 mL minꢃ1. Each ca. 8 mg of optically active sele-
noximine was collected from the first and second eluates, respec-
tively.
(S)-(þ)-N-Tosyl(phenyl)-p-tolylselenoximine {(S)-(þ)-1}:
Colorless oil; 100% ee; ½ꢀꢂD þ11:3 (c 1.22, CHCl3); CD (MeCN)
ꢃ
226 ([ꢄ] ꢃ1:44 ꢁ 104), 241 ([ꢄ] 2:43 ꢁ 104), 273 ([ꢄ]
1
7:85 ꢁ 102). H and 13C NMR were almost the same as those of
N-Tosyl( p-methoxyphenyl)phenylselenoximine (2):
Mp
the racemic one.
(R)-(ꢀ)-N-Tosyl(phenyl)-p-tolylselenoximine {(R)-(ꢀ)-1}:
Colorless oil; 100% ee; ½ꢀꢂD ꢃ12:1 (c 1.05, CHCl3); CD (MeCN)
54.0–56.0 ꢄC (colorless amorphous); 1H NMR (500 MHz, CDCl3)
ꢁ 2.37 (s, 3H), 3.86 (s, 3H), 7.06 (d, 2H, J ¼ 8:9 Hz), 7.22 (d, 2H,
J ¼ 8:2 Hz), 7.60 (t, 2H, J ¼ 8:0 Hz), 7.66 (t, 1H, J ¼ 8:0 Hz),
7.90 (d, 2H, J ¼ 8:0 Hz), 7.95 (d, 2H, J ¼ 8:9 Hz), 8.01 (d, 2H,
J ¼ 8:2 Hz); 13C NMR (125 MHz, CDCl3) ꢁ 21.5, 55.9, 115.8,
126.5, 127.1, 129.2, 129.3, 130.4, 130.6, 134.2, 141.1, 141.5,
142.1, 164.2; 77Se NMR (95 MHz, CDCl3) ꢁ 890; IR (KBr) ꢂmax
3061, 2943, 2579, 1585, 1491, 1446, 1411, 1301, 1285, 1264,
1173, 1143, 1087, 1061, 1020, 927 (N=Se=O), 831, 815, 745,
711, 682, 573, 549, 514, 463, 380 cmꢃ1; UV (MeCN) ꢃmax 227
(" 5:01 ꢁ 104), 248 (" 4:45 ꢁ 104) nm; MS m=z 264 {Mþ(80Se)-
C7H7NO3S, 66%}, 262 {Mþ(78Se)-C7H7NO3S, 25%}, 184
(100%), 169 (25%), 155 (22%), 91 (66%), 77 (25%), 65 (27%).
Anal. Calcd for C20H19NO4SSe: C, 53.57; H, 4.27; N, 3.12%.
Found: C, 53.09; H, 4.32; N, 3.04%.
ꢃ
226 ([ꢄ] 1:70 ꢁ 104), 241 ([ꢄ] ꢃ2:38 ꢁ 104), 273 ([ꢄ]
ꢃ1:09 ꢁ 103). 1H and 13C NMR were almost the same as those
of the racemic one.
(S)-(þ)-N-Tosyl( p-methoxyphenyl)phenylselenoximine {(S)-
(þ)-2}: Colorless oil; 100% ee; ½ꢀꢂD þ16:1 (c 1.09, CHCl3); CD
1
(MeCN) ꢃ 229 ([ꢄ] ꢃ8:07 ꢁ 104), 252 ([ꢄ] 6:27 ꢁ 104). H and
13C NMR were almost the same as those of the racemic one.
(R)-(ꢀ)-N-Tosyl( p-methoxyphenyl)phenylselenoximine
{(R)-(ꢀ)-2}: Colorless oil; 100% ee; ½ꢀꢂD ꢃ15:5 (c 1.01, CHCl3);
1
CD (MeCN) ꢃ 229 ([ꢄ] 9:84 ꢁ 104), 251 ([ꢄ] ꢃ6:03 ꢁ 104). H
and 13C NMR were almost the same as those of the racemic one.
(þ)-N-Tosyl(phenyl)( p-trifluoromethylphenyl)selenoximine
{(þ)-3}: Mp 108.0–109.5 ꢄC (decomp, colorless powder); 100%
ee; ½ꢀꢂD þ44:6 (c 1.01, CHCl3); CD (MeCN) ꢃ 224 ([ꢄ]
1:04 ꢁ 104), 238 ([ꢄ] ꢃ6:76 ꢁ 103), 276 ([ꢄ] 1:43 ꢁ 103). 1H
and 13C NMR were almost the same as those of the racemic one.
(ꢀ)-N-Tosyl(phenyl)( p-trifluoromethylphenyl)selenoximine
{(ꢀ)-3}: Mp 108.0–110.0 ꢄC (decomp, colorless powder); 100%
ee; ½ꢀꢂD ꢃ42:4 (c 1.12, CHCl3); CD (MeCN) ꢃ 225 ([ꢄ]
ꢃ1:01 ꢁ 104), 239 ([ꢄ] 7:26 ꢁ 103), 277 ([ꢄ] ꢃ1:96 ꢁ 103). 1H
and 13C NMR were almost the same as those of the racemic one.
(S)-(þ)-N-Tosyl(2-naphthyl)phenylselenoximine {(S)-(þ)-
4}: Colorless oil; 100% ee; ½ꢀꢂD þ67:1 (c 1.09, CHCl3); CD
(MeCN) ꢃ 225 ([ꢄ] ꢃ5:87 ꢁ 104), 242 ([ꢄ] 1:03 ꢁ 105), 277 ([ꢄ]
N-Tosyl(phenyl)( p-trifluoromethylphenyl)selenoximine (3):
Mp 108.5–109.5 ꢄC (decomp, colorless prisms from ethyl ace-
tate–hexane); 1H NMR (500 MHz, CDCl3) ꢁ 2.38 (s, 3H), 7.24
(d, 2H, J ¼ 8:3 Hz), 7.64 (t, 2H, J ¼ 8:0 Hz), 7.72 (t, 1H, J ¼
8:0 Hz), 7.87 (d, 2H, J ¼ 8:6 Hz), 7.90 (d, 2H, J ¼ 8:3 Hz),
8.06 (d, 2H, J ¼ 8:0 Hz), 8.20 (d, 2H, J ¼ 8:6 Hz); 13C NMR
(125 MHz, CDCl3) ꢁ 21.3, 122.7 (q, J ¼ 273 Hz), 126.5, 127.2,
127.4 (q, J ¼ 7:3 Hz), 127.9, 129.2, 130.7, 134.8, 135.9 (q, J ¼
33 Hz), 139.4, 141.1, 142.5, 144.4; 77Se NMR (95 MHz, CDCl3)
ꢁ 887; IR (KBr) ꢂmax 3093, 1598, 1496, 1448, 1402, 1323, 1144,
1088, 1054, 1011, 997, 915 (N=Se=O), 839, 815, 745, 710, 692,
591, 573, 549, 498, 465, 392 cmꢃ1; UV (MeCN) ꢃmax 227 ("
2:27 ꢁ 104), 264 (sh, " 3:02 ꢁ 103) nm; MS m=z 300
{Mþ(80Se)-C7H7NO3S, 62%}, 298 {Mþ(78Se)-C7H7NO3S,
28%}, 221 (100%), 156 (22%), 91 (40%), 77 (45%), 65 (21%).
Anal. Calcd for C20H16F3NO3SSe: C, 49.08; H, 3.91; N, 2.86%.
Found: C, 49.46; H, 3.51; N, 2.91%.
1
9:16 ꢁ 104). H and 13C NMR were almost the same as those of
the racemic one.
(R)-(ꢀ)-N-Tosyl(2-naphthyl)phenylselenoximine {(R)-(ꢀ)-
4}: Colorless oil; 100% ee; ½ꢀꢂD ꢃ65:0 (c 1.09, CHCl3); CD
(MeCN) ꢃ 226 ([ꢄ] 6:61 ꢁ 104), 241 ([ꢄ] ꢃ9:90 ꢁ 104), 277 ([ꢄ]
ꢃ7:18 ꢁ 103). 1H and 13C NMR were almost the same as those
of the racemic one.
N-Tosyl(2-naphthyl)phenylselenoximine (4):
Mp 114.0–
ꢄ
116.0 C (decomp, colorless powder from ethyl acetate–hexane);
1H NMR (500 MHz, CDCl3) ꢁ 2.36 (s, 3H), 7.21 (d, 2H, J ¼ 8:3
Hz), 7.61 (t, 2H, J ¼ 8:0 Hz), 7.65–7.71 (m, 4H), 7.91–7.95 (m,
3H), 8.00 (d, 1H, J ¼ 8:0 Hz), 8.04 (d, 1H, J ¼ 8:9 Hz), 8.09 (d,
2H, J ¼ 8:3 Hz), 8.65 (s, 1H); 13C NMR (125 MHz, CDCl3) ꢁ
21.3, 121.2, 126.5, 127.2, 128.1, 128.2, 129.0, 129.1, 129.2,
129.8, 130.5, 130.9, 132.5, 134.3, 135.4, 137.0, 140.6, 141.5,
142.2; 77Se NMR (95 MHz, CDCl3) ꢁ 891; IR (KBr) ꢂmax 3058,
2366, 1597, 1446, 1300, 1143, 1087, 911 (N=Se=O), 814, 744,
710, 682, 572, 549, 475, 462 cmꢃ1; UV (MeCN) ꢃmax 237 ("
8:28 ꢁ 103), 270 (sh, " 1:70 ꢁ 103) nm; MS m=z 284
{Mþ(80Se)-C7H7NO3S, 35%}, 282 {Mþ(78Se)-C7H7NO3S,
22%}, 204 (100%), 155 (16%), 126 (19%), 115 (42%), 91
(55%), 77 (25%), 65 (18%). Anal. Calcd for C23H19NO3SSe: C,
58.97; H, 4.09; N, 2.99%. Found: C, 58.60; H, 4.13; N, 3.02%.
Optical Resolution of Racemic Selenoximines by Means of
Medium-Pressure Column Chromatography Using an Optical-
ly Active Column. Typically, the racemic selenoximine (25 mg),
(S)-(þ)-N-Tosyl(phenyl)-p-tolylsulfoximine {(S)-(þ)-5}:13
Colorless oil; 1H NMR (500 MHz, CDCl3) ꢁ 2.38 (s, 3H), 2.40
(s, 3H), 7.22 (d, 2H, J ¼ 8:0 Hz), 7.30 (d, 2H, J ¼ 8:3 Hz), 7.50
(t, 2H, J ¼ 8:3 Hz), 7.57 (t, 1H, J ¼ 8:3 Hz), 7.84 (d, 2H, J ¼
8:3 Hz), 7.87 (d, 2H, J ¼ 8:3 Hz), 7.98 (d, 2H, J ¼ 8:0 Hz);
13C NMR (125 MHz, CDCl3) ꢁ 21.4, 21.5, 126.6, 127.5, 127.7,
129.1, 129.4, 130.1, 133.5, 136.6, 140.1, 140.9, 142.6, 145.0;
100% ee; ½ꢀꢂD þ20:4 (c 0.75, CHCl3); CD (MeCN) ꢃ 223 ([ꢄ]
ꢃ9:11 ꢁ 103), 243 ([ꢄ] 1:41 ꢁ 104), 276 ([ꢄ] 1:46 ꢁ 103).
Stability of Optically Active Selenoximines. To an acetoni-
trile solution (5 mL) of optically active selenoximine (2.3 mmol)
was added water (0.5 mL), 1 M-HClaq (1 M = 1 mol dmꢃ3) (0.2
mL), or 1 M-NaOHaq (0.2 mL) and stirred at room temperature
for 24 h. No racemization was observed in all of the selenoximines
under all of the conditions. No decomposition was observed in the
acetonitrile–water solution in all of the selenoximines. However,
they were partly hydrolyzed to the corresponding selenones and
p-toluenesulfonamide under both acidic and basic conditions, as